Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Gamida Cell Says Planning To Initiate Rolling BLA Submission For Omidubicel; Full BLA Submission On Track For 1H 2022

Planning to initiate rolling BLA submission for omidubicel following positive Type B meeting with FDA Full BLA submission on track for first half of 2022

FDA warns this brand of at-home Covid test may give false results

Anyone who has used these tests in the past two weeks should re-test to confirm ‘questionable results’

The Independent UK

FDA Approves PolarityTE's Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer

FDA Approves PolarityTE's Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

FDA Grants Fast Track Tags To Drug Candidates For Antares Pharma, Celcuity, Celularity

34 Stocks Moving In Tuesday's Mid-Day Session

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device Designation for the treatment of chronic chemo induced peripheral neuropathy with its wearable neurostimulation technology.

NeuroMetrix Shares Rally On FDA Breakthrough Tag For Neurostimulation Device

FDA Issues Clinical Hold On Dyne's IND For Duchenne Muscular Dystrophy Program

inkl

Read news from The Economist, FT, and more,
with one subscription

FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies

FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies

Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS

Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS

New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism

FDA Clears Surgalign's HOLO Portal Surgical Guidance System For Spine Procedures

FDA Clears Surgalign's HOLO Portal Surgical Guidance System For Spine Procedures

Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US

Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US

Gilead Sciences Inc (NASDAQ: GILD) recently notified the FDA of its decision to

FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis

FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis

Along with AbbVie Inc's (NYSE: ABBV)

$FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older$

FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older

FDA: Medtronic slow to update, recall defective insulin pumps for diabetes patients

While the U.S. Food and Drug Administration acknowledges Medtronic is actively working on fixing issues within its diabetes business, especially in regard to some of its insulin pumps, it says the steps took too long and are not enough.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

Pune’s oxygen demand rises slightly; FDA claims readiness

PUNE: The daily oxygen demand across Pune district has grown slightly to 90-95 metric tonnes (MT) as compared to the 85-90 MT in a week-ago period, with Food and Drug Administration officials (FDA) claiming preparedness to meet any jump in oxygen demand.

HTBX: RapidVax Unveiled; Elusys Acquisition

By John Vandermosten, CFA NASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT

What temperature should a refrigerator be? Keep your food in optimal conditions

Find out what temperature a refrigerator should be to keep your food safe to eat.

MobileHelp review

MobileHelp, a leading manufacturer of medical alert systems, offers cost savings. It collaborates with Rapid Response for call center services and focuses on innovative, compact devices.

Get all your
news in one place.

100's of premium titles.
One news app.

1 … 272 273 274 275

People

John Vandermosten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Food and Drug Administration

Gilead Sciences Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

402,624 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play